Evidence map›Paper›PMID 35701415›Full record

ArticleNature communications2022

Automated detection and segmentation of non-small cell lung cancer computed tomography images.

Sergey P Primakov, Abdalla Ibrahim, Janita E van Timmeren, Guangyao Wu, Simon A Keek, Manon Beuque, Renée W Y Granzier, Elizaveta Lavrova, Madeleine Scrivener, Sebastian Sanduleanu and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sergey P PrimakovThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-3856-9740
Abdalla IbrahimThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-4138-5755
Janita E van TimmerenThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-8166-6853
Guangyao WuThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Simon A KeekThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Manon BeuqueThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-6804-5908
Renée W Y GranzierDepartment of Surgery, GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0003-1398-7249
Elizaveta LavrovaThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-2751-790X
Madeleine ScrivenerDepartment of Radiation Oncology, Cliniques universitaires St-Luc, Brussels, Belgium.
Sebastian SanduleanuThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Esma KayanThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Iva HalilajThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-7805-7918
Anouk LenaersThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-7354-7355
Jianlin WuDepartment of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
René MonshouwerDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-9611-3901
Xavier GeetsDepartment of Radiation Oncology, Cliniques universitaires St-Luc, Brussels, Belgium.
Hester A GietemaDepartment of Radiology and Nuclear Medicine, GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.ORCID 0000-0001-6077-1446
Lizza E L HendriksDepartment of Pulmonary Diseases, GROW - School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.ORCID 0000-0002-3521-2535
Olivier MorinDepartment of Radiation Oncology, University of California San Francisco, San Francisco, California, CA, USA.ORCID 0000-0002-9240-5704
Arthur JochemsThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Henry C WoodruffThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-7911-5123
Philippe LambinThe D-Lab, Department of Precision Medicine, GROW- School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. philippe.lambin@maastrichtuniversity.nl.ORCID 0000-0001-7961-0191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection and segmentation of abnormalities on medical images is highly important for patient management including diagnosis, radiotherapy, response evaluation, as well as for quantitative image research. We present a fully automated pipeline for the detection and volumetric segmentation of non-small cell lung cancer (NSCLC) developed and validated on 1328 thoracic CT scans from 8 institutions. Along with quantitative performance detailed by image slice thickness, tumor size, image interpretation difficulty, and tumor location, we report an in-silico prospective clinical trial, where we show that the proposed method is faster and more reproducible compared to the experts. Moreover, we demonstrate that on average, radiologists & radiation oncologists preferred automatic segmentations in 56% of the cases. Additionally, we evaluate the prognostic power of the automatic contours by applying RECIST criteria and measuring the tumor volumes. Segmentations by our method stratified patients into low and high survival groups with higher significance compared to those methods based on manual contours.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsAlgorithmsHumansProspective StudiesTomography, X-Ray Computed

Identifiers

PMID35701415
PMCPMC9198097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.